Unravelling subjectivity, embodied experience and (taking) psychotropic medication

Abstract

This paper explores how distinctions between ‘intended’ and ‘side’ effects are troubled in personal narratives of taking psychotropic medications. Grounded in interviews with 29 participants diagnosed with mental illness in Victoria, Australia between February and December 2014, we consider how people interpret pharmaceutical compounds beyond their desired or intended effects, and how such effects shape and transform subjectivity and their relationship with their bodies. This paper contributes to recent discussions of mental illness and medication effects, informed by feminist science studies. It emphasises the co-constitution of social, affective and material relations in the context of ‘taking’ psychotropic medication. This paper discusses three key themes as important to the phenomenology of the nexus of illness and psychotropic medication: movement, ambivalence, and sociality. Our analysis demonstrates how psychotropic drugs are productive of subjectivity through their promises and potential, their unexpected harms and the institutions from which they are inseparable.

Gender Influences on Physical Activity Awareness of Adolescents and Their Parents

“…As the basic concept of this body of research, perception refers to sensory awareness and depends on the knowledge and opinions held by the individual about what it is being assessed [ 5 , 6 , 7 ]. If we talk specifically about perception of PA, subjectivity is also present [ 8 ]. That is, when people are asked to assess their own level of PA, their previous knowledge could determine the realism of their assessments [ 9 ].…”

Ingestible sensors, data, and pharmaceuticals: Subjectivity in the era of digital mental health

“…2 In biomedical approaches to mental health, a well-documented issue commonly associated with psychiatric drug treatment, especially antipsychotics, is adherence to treatment plans (Morrison et al, 2015;Pilgrim et al, 2011). The adverse effects of antipsychotics are often debilitating, including weight gain, sexual dysfunctions, nausea, and vomiting, and can lead people to modify their doses by themselves, or cease taking their medication (Flore et al, 2019;Morrison et al, 2015). Issues associated with taking antipsychotics can be further compounded by the individual's position in the mental health system; for example, they can be prescribed as part of a Community Treatment Order under which taking antipsychotic medication is strictly policed (Brophy et al, 2019).…”

“…This body of research has highlighted how taking antipsychotics affect people's intimate, social, and economic lives, the difficult impacts many experience, and how they either cease taking medication, or adjust their doses, sometimes without consulting their physician (Morrison et al, 2015;Pilgrim et al, 2011). Flore et al (2019) have sought to highlight how individuals taking antipsychotics do not always distinguish between "intended" and "side" effects when recounting their experiences with antipsychotics. And mental health advocates have spoken about the broader impacts of medication and its adverse effects, such as stigma, difficulties with intimacy, and limited or lost ability to work (Russo, 2018).…”

“…A new materialist argument demands that we consider how Abilify MyCite and its entanglement with mental health diagnoses generate affective proximity. The term "affective proximity" here refers to how people may form relations of attachment and ambivalence with acts, behaviors, moods, and embodied states that come to be assigned a diagnosis (Flore et al, 2019;Callard, 2014;Trivelli, 2014). It is not merely a diagnosis that somebody "has" or a diagnosis that one is passively assigned, rather it is a diagnosis that one relates to affectively (and produces, contests, and affirms) along with Abilify MyCite.…”

Mental health service users experiences of medication discontinuation: a systematic review of qualitative studies

“…This has resulted in large-scale correlational studies that focus on identifying factors that are associated with non-adherence. These studies are often framed within a language of non-compliance, non-adherence and medication refusal (Flore et al, 2019;Ascher-Svanum et al, 2010;Moritz et al, 2013;Sapra et al, 2014), with a view to developing more robust medication adherence strategies. Rather than perceiving an individual's decision to discontinue medication as a rationally thought out personal choice, decisions to manage mental distress without medication tends to be viewed as a consequence of an individual's "lack of insight" into the nature of their problems (Bulow et al, 2016;Chakrabarti, 2014).…”